Metis TechBio inks up to $1.1 billion deal with Eli Lilly for drug delivery tech
Summary
Metis TechBio has agreed to a partnership with pharmaceutical company Eli Lilly worth up to $1.1 billion. The collaboration will focus on utilizing specialized technology for delivering drugs.
Source: Read the full story at Stock Market News
Disclaimer: This content is for informational and educational purposes only and is not financial, investment or trading advice. Tech & Money Press is not a registered investment adviser or broker-dealer. Trading stocks, options and crypto involves substantial risk, including the loss of your entire investment. Do your own research and consult a licensed professional before making any financial decision. The authors may hold positions in the securities mentioned. News summaries are written with AI assistance from the original publisher's report and may contain errors; always check the original source. Full disclaimer.